Skip to main content

Fiscal Wizard · Single-issue tearsheet

EW / Aug 31, 2026 Run #19061

EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Composite verdict

B 66.4 / 100
Bullish setup · Trend Following 9 drivers · 2 gates blocking
  • Chaikin Money Flow
  • MA Rejection
  • Double 7s
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 5th of 10 in Medical Devices

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 23 signals0% Bear
Momentum Bullish 92Mean-reversion Neutral 56
  • Pullback buyOversold in an uptrend — a pullback buy: mean-reversion aligned with the primary trend, the high-value case for an oversold signal. (medium confidence)
Where value comes fromMargin of safety -77%
Asset value $17.93Earnings power value $24.28Price $90.85

Priced above its no-growth earnings power value ($24.28/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

32.9 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
FCF Margin 90
Margin of Safety 0
Operating Margin 82
Earnings Yield 0
Net Margin 82
EPS Growth (YoY) 0

Technicals Bullish

99.9 / 100

Bullish setup leads (Chaikin Money Flow, MA Rejection, Double 7s); bears gated by guards. · 44 signals shown.

Strongest
Weakest
Chaikin Money Flow 85
MA Rejection 83
TRIX Zero-Line 79

Risk Gates

2 blocking 6 caution

2 guards active, 18 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for EW.